Pemoline for Cocaine Abuse - 7
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Pemoline (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Thomas R Kosten, M.D., Principal Investigator, Affiliation: VA Connecticut Healthcare System
Summary
The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.
Clinical Details
Official title: Pemoline for Cocaine Abuse
Study design: Treatment
Primary outcome: Side effectsDrug use Retention
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
VA Connecticut Healthcare System, New Haven, Connecticut 06519, United States
Additional Information
Last updated: June 23, 2005
|
